Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Remicalm logo — Enhancing early detection and effective treatment of various...

Remicalm

Enhancing early detection and effective treatment of various cancers with innovative medical imaging and diagnostic devices for better outcomes.

Founded 2006 United States Houston, United States 1 employees Debt Financing Total: $500.00K Health Care, Manufacturing

General Information

Company Name Remicalm
Founded Year 2006
Location United States Houston, United States
Employees 1
Industries Health Care, Manufacturing
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Remicalm. To contact Remicalm, visit remicalm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Remicalm compare?

A PDF of Remicalm and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Remicalm soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Remicalm

Remicalm, LLC is a medical diagnostic and imaging device company established in 2006 and headquartered in Houston, Texas. The company focuses on designing, manufacturing, and marketing innovative medical devices for cancer diagnostic, screening, imaging, and monitoring within the United States. Their products target imaging and diagnosing various cancers, including oral, cervical, skin, bladder, esophagus, and colon cancers. With a slogan of "Enhancing early detection and effective treatment of various cancers," Remicalm's offerings are geared towards early detection and treatment of cancers and pre-cancers occurring in the cells lining the internal and external surfaces of the body. Notably, the company received a $500.00K debt financing investment on 12 August 2009. The incorporation of innovative medical imaging and diagnostic devices positions Remicalm at the forefront of the health care and manufacturing industries. The company's focus on improving cancer outcomes through early detection aligns with the growing emphasis on preventive healthcare. This could present a compelling opportunity for venture capital investors seeking to support groundbreaking advancements in the medical technology sector.

Business keywords: medical imaging, diagnostic devices, cancer detection, cancer treatment, early detection, screening devices, imaging devices, cancer diagnostic devices, oncology, cancer monitoring devices, biomedical devices, cancer diagnostics, cancer screening

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $500.00K -
12 Aug 2009

Remicalm Alternatives & Competitors

View All Alternatives
Remicalm vs
Endiatx
Endiatx United States

A team of engineers and physicians developing PillBot™, a moving pill-sized camera for easy, at-home...

Non Equity Assistance
32 employees
Health Care, Manufacturing
Compare Remicalm vs Endiatx
Remicalm vs
SmartPill
SmartPill

Pioneering innovative ingestible capsules for precise gastrointestinal diagnostics and therapies

Venture round
Health Care, Manufacturing
Remicalm vs
Heart Force Medical Inc.
Heart Force Medical Inc. Canada

Changing the way people detect heart disease.

8 employees
Health Care, Manufacturing
View all alternatives

FAQ About Remicalm

Enhancing early detection and effective treatment of various cancers with innovative medical imaging and diagnostic devices for better outcomes.
Remicalm was founded in 2006.
Remicalm is headquartered in Houston, United States.
Remicalm operates in Health Care and Manufacturing. Its work centres on medical imaging, diagnostic devices, cancer detection and cancer treatment.
Remicalm has approximately 1 employees.
Remicalm has completed 1 funding round, raising a total of $500.00K. The latest funding stage is Debt Financing.
Top alternatives and competitors to Remicalm include Endiatx, SmartPill, Heart Force Medical Inc., Nucleix Ltd., ViewRay, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Remicalm and Endiatx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Remicalm, https://bouncewatch.com/company/remicalm, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout